Publications
45
Citations
232
Est. group size
~1
Recurring co-author estimate
Active years
14
Publishing since 2013
Tyler Haddad's publicly indexed work centers on using genetic testing methods (next-generation sequencing) to help guide treatment decisions for head and neck squamous cell carcinoma, a type of cancer affecting the mouth, throat, and related areas. Additional records include case reports on unusual causes of respiratory symptoms such as asthma. The bulk of the recent record consists of supplementary data files linked to a single 2023 study rather than a broad series of distinct research projects.
Publication output was low and steady from 2017-2022, then spiked sharply in 2023 (largely due to multiple supplementary files from one study) before returning to a lower, modest level in subsequent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Table 1A and Table 1B from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Legend from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Figure 5 from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Figure 6 and 7 from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Legend from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Figure 3 from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Figure 6 and 7 from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Figure 2 from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Figure 4 from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Figure 5 from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Figure 1 from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Table 1A and Table 1B from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Data from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Data from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Figure 2 from Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
2023
- CHEST Journal×4
- Journal of Clinical Oncology×3
- Cancer Immunology Immunotherapy×2
- Clinical Lung Cancer×1
- Clinical Cancer Research×1
- James W. Rocco
Medicine · The Ohio State University
- Marcelo Bonomi
Medicine · The Ohio State University
- Catherine T. Haring
Medicine · The Ohio State University
- Darrion Mitchell
Medicine · The Ohio State University
- Priyanka Bhateja
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile